Last updated on 26 Apr 2024
Owner Info
Revance Therapeutics, Inc.
7555 Gateway Blvd.
Newark CA 94560, UNITED STATES OF AMERICA
Serial Number
2169292 filed on 10 Feb 2021
Correspondent
Maren C. Perry King & Spalding LLP
1185 Avenue of the Americas,
New York NY 10036,
UNITED STATES OF AMERICA
2169292
10 Feb 2021
NA
WORD
11 Aug 2020
US
Status Date | Action Taken |
---|---|
26th Apr 2024 | Status change to Voided |
24th Jun 2021 | International Registration in Australia Protected correspondence sent |
23rd Jun 2021 | IP Right Registration Published |
23rd Jun 2021 | Status change to Registered/Protected |
17th Apr 2021 | Application Accepted correspondence sent |
16th Apr 2021 | IP Right has been Examined |
16th Apr 2021 | IP Right Acceptance Published |
16th Apr 2021 | Status change to Accepted |
14th Apr 2021 | Awaiting examination |
14th Apr 2021 | Examination expedited |